[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100538877":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":34,"locations":43,"responsibleParty":60,"collaborators":24,"id":62,"slug":24,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":24,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":24,"enrollmentInfo":70,"targetDuration":24,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":45,"whyStopped":24,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Scripps Whittier Diabetes Institute","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"CGM Group","EXPERIMENTAL","Participants will be provided continuous glucose monitors (Dexcom G7) to monitor blood glucose for the entire duration of this study (i.e., one new device every 10 days for a total of 18 devices to last up to 6 months).",[13,14],"Other: Dulce Digital Text Messaging Intervention","Other: CGM Device",{"label":16,"type":6,"description":17,"interventionNames":18},"Usual Care Blood Glucose Monitoring Group","Participants will use standard blood glucose monitoring devices that are covered by health insurance.",[13],[20,25],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Dulce Digital Text Messaging Intervention","Text-based education support program:\n\n* Participants will receive text messages about diabetes and how to take care of diabetes and health. Participants will receive 2-3 messages every day for first 3 months, and then will slowly decrease over the last 3-months.\n* Participants will also receive text messages that will ask them to test their blood sugar and text back blood sugar reading.",[9,16],null,{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"CGM Device","Participants will be provided continuous glucose monitors (Dexcom G7) to actively monitor blood glucose for the entire duration of this study (i.e., one new device every 10 days for a total of 18 devices to last up to 6 months). In addition, participants will attend an information session (group or individual; in-person or virtual) that will provide instructions on using continuous glucose monitors.",[9],[30],{"name":31,"affiliation":32,"role":33},"Athena Philis-Tsimikas, MD","Scripps Health","PRINCIPAL_INVESTIGATOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":24,"email":39},"Kallie Brown, PhD","CONTACT","858-258-3555","brown.kallie@scrippshealth.org",{"name":31,"role":37,"phone":41,"phoneExt":24,"email":42},"877-944-8843","philis-Tsimikas.athena@scrippshealth.org",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","San Diego","California","92037","United States",{"type":51,"coordinates":52},"Point",[53,54],-117.16472,32.71571,{"lat":54,"lon":53},[57,59],{"name":31,"role":37,"phone":41,"phoneExt":24,"email":58},"tsimikas.athena@scrippshealth.org",{"name":36,"role":37,"phone":38,"phoneExt":24,"email":39},{"type":61,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100538877",false,"NCT06296550","Enhancing Digitally Delivered Diabetes Education With Real-Time CGM","Enhancing Digitally Delivered Diabetes Education With Real-Time CGM: A Comparative Study in People With Type 2 Diabetes","Inclusion Criteria:\n\n* Diagnosed with type 2 diabetes\n* Are not currently using a CGM\n* Are not using insulin therapies\n* Speak English, Spanish or Arabic\n* Have A1c between 7.5% and 12.0% in last 90 days\n* Have a cellphone that can receive\u002Fsend text messages and counts steps\n\nExclusion Criteria:\n\n* Are using insulin therapies\n* Are pregnant\n* Are currently using a CGM\n* Are currently participating in another diabetes-related study","ALL","18 Years",{"count":71,"type":72},140,"ESTIMATED","INTERVENTIONAL",[75],"NA","The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.",[78],"Diabetes Type 2",[80,81,82],"Diabetes","CGM","Diabetes Education","2026-03-04",{"date":85,"type":86},"2026-03-06","ACTUAL",{"date":88,"type":86},"2025-04-03",{"date":90,"type":72},"2027-04-30",{"name":5,"class":6},1]